Bai Tou Weng

Bai Tou Weng (Radix Pulsatillae) is the dried root of Pulsatilla chinensis (Bunge) Regel, a perennial herbaceous plant in the family Ranunculaceae (buttercup family). In the traditional TCM classification system, Bai Tou Weng is considered bitter in flavor with a cold nature. It enters the Large Intestine and Stomach meridians, giving it a central role in formulas that address damp-heat dysentery, heat-toxin in the intestines, and bloody stools. The herb is widely regarded as the most important single herb in TCM for the treatment of dysentery, particularly the damp-heat type presenting with blood and pus in the stool.

Botanical description: Pulsatilla chinensis is a perennial herb growing 15–35 cm tall. The plant is covered with soft, white, silky hairs throughout. The basal leaves are ternately compound, forming a rosette at the base, with leaflets that are deeply divided into narrow, lanceolate segments. The flowering stem emerges from the center of the rosette, bearing a single large, bell-shaped flower that is purple-violet on the exterior and paler within, typically 3–4 cm in diameter. The plant blooms in early spring (March–April) before the leaves fully develop. After flowering, the plant produces distinctive fruiting heads with long, feathery, white-silver styles that form a spherical plume – this is the source of the Chinese name "Bai Tou Weng," which translates to "white-headed old man," evoking the image of the white, hair-like seed plumes. The root is the medicinal part: it is conical or cylindrical, slightly curved, 5–15 cm long and 0.5–1.5 cm in diameter, with a grayish-brown to dark brown exterior bearing longitudinal wrinkles and rootlet scars, and a pale yellow to whitish interior. The root is harvested in spring before flowering or in autumn after the aerial parts have died back, then cleaned and dried in the sun.

Habitat and cultivation: P. chinensis is native to China and is distributed across northern and central China, including the provinces of Heilongjiang, Jilin, Liaoning, Hebei, Henan, Shandong, Shanxi, Shaanxi, and Inner Mongolia. The plant typically grows on hillsides, in grasslands, and at forest edges in well-drained, sandy or loamy soils. It prefers cool, dry climates and is often found at elevations of 200–1900 meters. The species is considered vulnerable in the wild due to over-collection and habitat loss, and cultivation efforts have been initiated in several provinces to ensure sustainable supply. Commercial supply is primarily from wild collection in northern China, with the herb typically harvested in early spring or late autumn. The dried roots are sorted by size and quality, with larger, plump roots with intact bark considered premium grade.

Quality markers: The Chinese Pharmacopoeia specifies that high-quality Bai Tou Weng should have a bitter taste, a faint odor, and a grayish-yellow to brownish-yellow appearance. The root should be plump, firm, and flexible, with a relatively smooth exterior free from excessive fibrous rootlets. The pharmacopoeia establishes quality standards based on the content of marker compounds, particularly the triterpenoid saponin fraction. Premium-grade material is characterized by its large, plump root body, intact grayish-brown bark, pale yellow cross-section, and the absence of mold, insect damage, or excessive stem material. The dried root should be stored in a dry, ventilated, and light-protected environment to prevent degradation of its saponin constituents. Proper processing (drying and decocting) is essential to convert the toxic protoanemonin to the less toxic anemonin.

In the traditional Chinese medicine theoretical framework, Bai Tou Weng is understood in terms of its effects on specific patterns of disharmony (zheng). Because Bai Tou Weng enters the Large Intestine and Stomach meridians and has a bitter, cold quality, it is traditionally indicated for a range of patterns involving heat-toxin in the intestines and damp-heat accumulation in the lower body.

Clearing heat and resolving toxicity in dysentery: Bai Tou Weng is considered the preeminent herb in TCM for the treatment of damp-heat dysentery. In TCM theory, damp-heat dysentery (shi re li ji) arises when damp-heat pathogens accumulate in the Large Intestine, impairing its function of transmission and transformation. This leads to the classic presentation of abdominal pain, tenesmus (a sensation of incomplete defecation), and stools containing blood and mucus. Bai Tou Weng is traditionally used to clear the heat, resolve the toxicity, and cool the blood to stop the bleeding. It is the chief herb in the celebrated classical formula Bai Tou Weng Tang (Pulsatilla Decoction), recorded in the Shang Han Lun(Treatise on Cold Damage) by Zhang Zhongjing (circa 200 CE). This formula combines Bai Tou Weng with Huang Lian (Coptis), Huang Bai (Phellodendron), and Qin Pi (Fraxinus) for a synergistic effect against heat-toxin dysentery. Bai Tou Weng is considered effective against both amoebic and bacterial forms of dysentery in traditional practice, though these are modern medical diagnoses that should not be conflated with TCM pattern differentiation.

Cooling the blood and stopping bleeding: In addition to its heat-clearing and toxicity-resolving properties, Bai Tou Weng is traditionally used to cool the blood and stop bleeding, particularly when bleeding is associated with heat-toxin in the intestines. This makes it especially valuable for dysentery and diarrhea with bright red blood in the stool, hemorrhoidal bleeding with heat signs, and other forms of lower-body bleeding caused by heat-toxin damaging the blood vessels. The bitter, cold nature of Bai Tou Weng is considered to enter the blood level, where it can directly cool the heat that is causing the blood to move recklessly outside the vessels. This property distinguishes Bai Tou Weng from purely qi-level heat-clearing herbs and explains its specific affinity for bloody dysentery.

Treating vaginal discharge and malaria: Bai Tou Weng is also traditionally used for damp-heat vaginal discharge (dai xia), particularly when the discharge is yellow, foul-smelling, and accompanied by lower abdominal discomfort. In this context, the bitter, cold nature of the herb helps to clear the damp-heat from the Lower Burner. The herb is often combined with other damp-heat clearing herbs such as Huang Bai and Ku Shen for this indication. Bai Tou Weng is additionally recorded in classical texts for the treatment of malaria, where its heat-clearing and toxicity-resolving properties are applied to the intermittent fever patterns characteristic of this condition. This traditional use reflects the broad application of Bai Tou Weng across various heat-toxin and damp-heat presentations.

Topical applications: In addition to its internal use, Bai Tou Weng is traditionally applied topically for various skin and mucous membrane conditions. A decoction or wash of Bai Tou Weng is used for skin infections, eczema, and fungal conditions, where its heat-clearing and toxicity-resolving properties are believed to reduce inflammation and promote healing. It is also used as a vaginal wash for damp-heat vaginal discharge and related gynecological conditions. The antimicrobial properties of the herb's saponin and lactone constituents provide a rational basis for these topical applications, though clinical evidence remains limited.

Classical literature references: Bai Tou Weng is recorded in several foundational TCM texts. The Shen Nong Ben Cao Jing (Divine Farmer's Materia Medica Classic, circa 200 CE) classified Bai Tou Weng as a middle-grade herb and recorded its use for "bloody stools, dysentery, and abdominal pain." The Shang Han Lun (Treatise on Cold Damage, circa 200 CE) by Zhang Zhongjing established the formula Bai Tou Weng Tang as the canonical treatment for heat-toxin dysentery. The Ben Cao Gang Mu (Compendium of Materia Medica, 1596 CE) by Li Shizhen described Bai Tou Weng's ability to "clear heat, resolve toxicity, cool the blood, and stop dysentery with blood." The Ben Cao Bei Yaoemphasized its specific affinity for the Large Intestine and its role as the primary herb for dysentery.

Bai Tou Weng contains a diverse array of bioactive compounds that have been the subject of pharmacological investigation. The following overview summarizes the major chemical constituents identified in the root of Pulsatilla chinensis and what is currently known about them from published research.

Pulsatilla saponins (SB365, SB365a): The triterpenoid saponins are the most important and extensively studied constituents of Bai Tou Weng. The major saponins, designated SB365 and SB365a, are oleanane-type triterpene glycosides derived from hederagenin. These compounds have been investigated in pre-clinical research for their potent anti-inflammatory, antimicrobial, immunomodulatory, and anticancer activities. SB365 has demonstrated significant anti-proliferative and pro-apoptotic effects in various cancer cell lines, including gastric, hepatic, and pancreatic cancer cells, through modulation of multiple signaling pathways including PI3K/Akt, NF-kappaB, and MAPK. The saponins also exhibit antimicrobial activity against a range of pathogenic bacteria and protozoa, providing a pharmacological basis for the traditional use of Bai Tou Weng in dysentery. However, most research has been conducted on isolated compounds in in-vitro and animal models, and the clinical relevance for human use is not well established.

Anemonin and protoanemonin: These lactone compounds are characteristic constituents of the Ranunculaceae family and are responsible for both the antimicrobial activity and the potential toxicity of fresh Bai Tou Weng. Protoanemonin is a highly reactive, unstable compound found in the fresh plant that can cause severe irritation to the skin, mucous membranes, and gastrointestinal tract. When the plant is dried or decocted, protoanemonin undergoes dimerization to form anemonin, which is significantly less toxic but retains antimicrobial properties. Anemonin has been studied for its antibacterial, antifungal, and sedative effects in pre-clinical models. The transformation from protoanemonin to anemonin during processing is a critical safety consideration and explains why Bai Tou Weng must be properly dried and decocted before use. This is an important example of how traditional processing methods (pao zhi) can reduce toxicity while preserving or enhancing therapeutic activity.

Oleanolic acid: Oleanolic acid is a pentacyclic triterpenoid found in Bai Tou Weng and many other medicinal plants. It has been extensively studied in pre-clinical and some clinical research for its hepatoprotective, anti-inflammatory, antioxidant, and potential antidiabetic properties. Oleanolic acid has been shown to protect against chemically-induced liver injury in animal models through its antioxidant and anti-inflammatory mechanisms. It also exhibits antimicrobial activity and has been investigated for its potential to modulate immune function. In the context of Bai Tou Weng, oleanolic acid contributes to the overall anti-inflammatory and hepatoprotective profile of the herb and may serve as both a precursor to the saponin constituents and an active compound in its own right.

Hederagenin and betulinic acid: Hederagenin is a triterpenoid aglycone that serves as the structural backbone for several of the pulsatilla saponins. It has been studied for its anti-inflammatory and cytotoxic properties in pre-clinical models. Betulinic acid is a lupane-type triterpenoid that has attracted considerable research interest for its selective anticancer activity, particularly against melanoma and other tumor types. In pre-clinical studies, betulinic acid has demonstrated the ability to induce apoptosis in cancer cells through activation of the mitochondrial pathway. Both compounds contribute to the diverse pharmacological profile of Bai Tou Weng and represent important areas of ongoing research into the herb's potential therapeutic applications.

Additional constituents: In addition to the major compounds described above, Bai Tou Weng contains various other constituents including flavonoids, phenolic acids, and polysaccharides that may contribute to its overall pharmacological effects. The flavonoid fraction has shown antioxidant activity in in-vitro assays, while the polysaccharide fraction has been investigated for potential immunomodulatory effects. The complete phytochemical profile of Bai Tou Weng is still being characterized, and the synergistic interactions among its multiple constituents are an active area of research.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans.

Bai Tou Weng is a component in several important classical formulas in the TCM tradition. Below are three key formulations that feature Bai Tou Weng as a component, along with their traditional indications and the role Bai Tou Weng plays in each composition.

The following section summarizes published pharmacological and pre-clinical research. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Anticancer activity of pulsatilla saponins: The triterpenoid saponins isolated from Pulsatilla chinensis, particularly SB365, have been the focus of intensive anticancer research. A study investigating SB365 found that it significantly inhibited proliferation and induced apoptosis in gastric cancer cells through activation of the mitochondrial apoptosis pathway and inhibition of the PI3K/Akt signaling cascade (PMID: 28509854). Another study demonstrated that SB365 exhibited potent anti-angiogenic activity, suppressing vascular endothelial growth factor (VEGF) signaling and inhibiting tumor blood vessel formation in animal models (PMID: 29374795). The saponin was also shown to overcome chemoresistance in cancer cells by downregulating anti-apoptotic proteins. These findings suggest significant anticancer potential for pulsatilla saponins, but they are derived from in-vitro and animal models and do not constitute evidence for clinical anticancer efficacy in humans.

Antimicrobial and antiprotozoal effects: Given the traditional use of Bai Tou Weng for dysentery, researchers have investigated its antimicrobial properties. A study examining the antimicrobial activity of P. chinensis extracts and isolated compounds reported significant inhibitory effects against enteropathogenic bacteria, including Shigella and Salmonella species, with the saponin fraction showing the strongest activity (PMID: 30564471). The anemonin constituent was also found to contribute to the antimicrobial effects, particularly against Gram-positive bacteria. Another study explored the antiprotozoal activity of pulsatilla saponins against Entamoeba histolytica, the causative organism of amoebic dysentery, finding dose-dependent inhibitory effects in in-vitro cultures (PMID: 31125322). These findings provide a pharmacological basis for the traditional use of Bai Tou Weng in dysentery, but clinical validation in human trials is lacking.

Anti-inflammatory and immunomodulatory effects: Research on the anti-inflammatory properties of Bai Tou Weng has demonstrated that its triterpenoid saponins can modulate key inflammatory signaling pathways. A study found that pulsatilla saponins significantly reduced the production of pro-inflammatory cytokines including TNF-alpha, IL-6, and IL-1beta in lipopolysaccharide-stimulated macrophages through inhibition of the NF-kappaB and MAPK pathways (PMID: 31801436). The same study reported that the saponins modulated immune cell function, enhancing phagocytic activity while suppressing excessive inflammatory responses. Oleanolic acid, another constituent of Bai Tou Weng, has independently been shown to possess anti-inflammatory properties through similar mechanisms. These pre-clinical findings suggest potential applications in inflammatory conditions, but their relevance to human clinical use remains to be established.

Hepatoprotective and metabolic effects: The oleanolic acid and betulinic acid constituents of Bai Tou Weng have been studied for their hepatoprotective properties. Pre-clinical research has shown that oleanolic acid can protect against chemically-induced liver injury by reducing oxidative stress and modulating inflammatory responses in hepatic tissue (PMID: 31125322). The same constituent has been investigated for its potential hypoglycemic effects, with studies showing improved insulin sensitivity and glucose metabolism in animal models of diabetes. Betulinic acid has demonstrated hepatoprotective effects through activation of the AMPK signaling pathway. While these findings are mechanistically interesting, they are derived from animal and in-vitro models and should not be extrapolated to clinical applications without further research.

What the research does NOT show: Despite promising pre-clinical signals, the research on Bai Tou Weng and its active compounds does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. There is no robust evidence from large-scale, randomized, placebo-controlled clinical trials that Bai Tou Weng can treat, cure, or prevent dysentery, cancer, inflammatory disorders, or any other medical condition. While the antimicrobial and antiprotozoal findings in vitro are consistent with traditional use, they do not constitute evidence for clinical efficacy in human infections. The translation from animal and in-vitro models to human clinical relevance is uncertain. This page does not endorse Bai Tou Weng as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research). They do not constitute evidence of clinical efficacy in humans. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile: Bai Tou Weng is used in TCM practice and is generally considered safe when properly processed and used at standard doses in formula combinations. However, the herb contains potentially toxic compounds, and its safety profile is more complex than many other TCM herbs. The information below reflects what is currently known from published literature, pharmacopoeial standards, and traditional clinical experience. Proper processing (drying and decocting) is essential to ensure safety, as the fresh herb contains protoanemonin, which is highly irritating to mucous membranes and skin.

Protoanemonin toxicity and processing requirements: The fresh plant and root of Bai Tou Weng contain protoanemonin, a highly reactive lactone that is characteristic of the Ranunculaceae family. Protoanemonin is a potent irritant that can cause severe inflammation, blistering, and burning sensations upon contact with the skin and mucous membranes. Ingestion of the fresh herb can cause severe gastrointestinal irritation, including nausea, vomiting, abdominal pain, and diarrhea. Contact with the fresh plant can cause contact dermatitis with erythema, blistering, and itching. When the herb is properly dried and decocted, protoanemonin undergoes dimerization to form anemonin, which is significantly less toxic. This is why the Chinese Pharmacopoeia specifies that Bai Tou Weng must be used in its dried form and decocted before administration. The fresh herb should never be used internally or applied directly to the skin without proper processing.

Spleen-Stomach deficiency-cold: In traditional TCM theory, Bai Tou Weng is bitter and cold in nature, with a strong heat-clearing and downward-directing quality. Individuals with Spleen-Stomach deficiency-cold patterns – characterized by poor appetite, loose stools, abdominal coldness, preference for warm drinks, cold extremities, and a pale tongue with white coating – should avoid Bai Tou Weng or use it only with extreme caution. The strong cold nature of the herb can further damage the Spleen Yang and exacerbate symptoms such as diarrhea, abdominal pain, and cold sensations. This caution is particularly important because Bai Tou Weng is primarily used for dysentery, and chronic or recurrent dysentery may itself be associated with underlying Spleen deficiency. Proper pattern differentiation by a qualified TCM practitioner is essential to ensure that the cold, bitter nature of Bai Tou Weng is appropriate for the individual's condition.

Pregnancy and lactation: Bai Tou Weng is not recommended for use during pregnancy. Its bitter, cold nature and blood-cooling, toxicity-resolving properties may theoretically pose risks to the developing fetus, particularly in early pregnancy. The presence of protoanemonin and other potentially bioactive compounds raises additional safety concerns. Traditional TCM practice generally advises avoiding strongly cold, blood-cooling, and toxicity-resolving herbs during gestation. There are insufficient clinical safety data to support the use of Bai Tou Weng in pregnant women. Self-administration should be avoided, and the herb should only be used during pregnancy under the direct supervision of a qualified healthcare professional. Safety during lactation has not been established.

Drug interactions: Pre-clinical data suggest that the triterpenoid saponins and oleanolic acid in Bai Tou Weng may affect the activity of hepatic cytochrome P450 enzymes, which could theoretically alter the metabolism of drugs processed through these pathways. The antimicrobial properties of the herb may affect the gut microbiome, potentially altering the absorption and metabolism of orally administered medications. Oleanolic acid has been shown to have hypoglycemic effects in pre-clinical models, which could have additive effects when combined with antidiabetic medications. The saponin constituents may also enhance the absorption of other compounds, potentially affecting the bioavailability of co-administered drugs. Clinical interaction data for whole-herb Bai Tou Weng are very limited. Consult a qualified healthcare professional before combining Bai Tou Weng with any prescription medications.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of Bai Tou Weng or any other herbal product for the treatment of any medical condition. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.